Abstract:AIM:To isolate and identify the biological characteristics of human colon cancer stem cells (SW1116 cells) and further study their proteome.METHODS:SW1116 cells were isolated and cultured with a serum-free medium (SFM). Sphere formation was assayed to observe the formation of colon cancer stem cell spheres. SW1116 cells were inoculated into a serum-containing medium for observing their differentiation characteristics. Proliferation curve and cross-resistance of SW1116 cells to different drugs were detected by MTT. Percentage of SP cells in SW1116 cells was detected with Hoechst33342 staining. Telomerase activity in SW1116cells was checked by polymerase chain reaction (PCR)-enzyme linked immunosorbent assay. Expressions of stem cell relevant genes and proteins were detected by reverse transcription-PCR and Western blot, respectively. Total protein was isolated from SW1116 cells by two-dimensional gel electrophoresis (2-DE) and differentially expressed proteins were identified by tandem mass spectrometry (MALDI-TOF/TOF).RESULTS:The isolated SW1116 cells presented as spheroid and suspension growths in SFM with a strong self-renewal, proliferation, differentiation and drug-resistance ability. The percentage of SP cells in SW1116 cells was 38.9%. The SW1116 cells co-expressed the CD133 and CD29 proteins. The telomerase activity in SW1116 cells was increased. The expressions of different stem cell relevant genes and proteins were detected. The proteomic analysis showed that the 26 protein spots were differently expressed in SW1116 cells and 10 protein spots were identified as ubiquitin fusion-degradation 1-like protein, nuclear chloride channel protein, tubulin β, Raichu404X, stratifin, F-actin capping protein α-1 subunit, eukaryotic translation elongation factor 1 delta isoform 2, hypothetical protein, glyceraldehyde-3-phosphate dehydrogenase and guanine nucleotide binding protein β polypeptide 2-like 1, respectively.CONCLUSION:SW1116 cells are biologically characterized by self-renewal, proliferation and differentiation, and the differently expressed proteins in SW1116 cells may be essential for isolating cancer stem cells.

Identification of Proteins of Human Colorectal Carcinoma Cell Line SW480 by Two-Dimensional Electrophoresis and MALDI-TOF Mass Spectrometry

Proteome of Human Colon Cancer Stem Cells: A Comparative Analysis

Proteomic Analysis of Differentially Expressed Proteins Between Metastatic and Non-Metastatic Human Colorectal Carcinoma Cell Lines.

Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis

Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.

Comparative Proteomics Analysis of Human Gastric Cancer

2-DE Profiling and Differential Analysis of Highly and Poorly Metastatic Human Gastric Carcinoma Cell Lines

Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS.

Nonreducing two-dimensional polyacrylamide gel electrophoretic analysis of human colonic proteins

[Differential Expression of Secretagogin and Glucose-Related Protein 78 in Colorectal Carcinoma: a Proteome Study].

Development and Preliminary Application of a Peptide Mass Fingerprinting Technique in Proteome Research.

A proteomic study on human lung adenocarcinoma cell line A549 by 2-DE and MALDI-TOF-MS

Differential Expression of Proteomics Models of Colorectal Cancer, Colorectal Benign Disease and Healthy Controls

Searching for Serum Tumor Markers for Colorectal Cancer Using a 2‐D DIGE Approach

Identification of Differentially Expressed Proteins in Colorectal Cancer by Proteomics: Down-regulation of Secretagogin

Quantitative proteome analysis of colorectal cancer-related differential proteins

Preoperatively Molecular Staging with CM10 ProteinChip and SELDI-TOF-MS for Colorectal Cancer Patients

Differential analysis of two-dimensional gel electrophoresis profile of human non-muscle-invasive bladder cancer and invasive bladder cancer tissue

Research on the differential expression of proteomics models of colorectal cancer, colorectal benign disease and healthy people

Use of tryptic peptide MALDI mass spectrometry imaging to identify the spatial proteomic landscape of colorectal cancer liver metastases.

Assessing Cmt Cell Line Stability by Two Dimensional Polyacrylamide Gel Electrophoresis and Mass Spectrometry Based Proteome Analysis